世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の医薬品サプライチェーンマネジメント市場予測 2023-2032


GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST 2023-2032

主な調査結果 世界の医薬品サプライチェーン管理市場は、2023年から2032年の予測期間中に年平均成長率8.84%で成長すると予測されています。市場の成長を後押しする主な要因としては、ヘルスケアにおけるクラウド... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Inkwood Research
インクウッドリサーチ
2023年5月20日 US$2,900
シングルユーザライセンス(印刷不可)
ライセンス・価格情報・注文方法はこちら
235 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

主な調査結果
世界の医薬品サプライチェーン管理市場は、2023年から2032年の予測期間中に年平均成長率8.84%で成長すると予測されています。市場の成長を後押しする主な要因としては、ヘルスケアにおけるクラウドコンピューティングシステムの適用拡大、GS1標準システムの採用、医療費削減への圧力の高まり、医薬品需要の急増、医薬品偽造の高い普及率などが挙げられます。
マーケットインサイト
医薬品サプライチェーンマネジメント(SCM)ソフトウェアは、医薬品の原産地から消費地までの流れを実装、計画、および制御するための設備です。医薬品業界のサプライチェーンには、有効成分、完成品、原材料、医療機器などが、メーカーから流通業者、薬局、医療施設、卸売業者へと移動することが含まれます。
医薬品業界では、医薬品の偽造が急増しており、効果的なサプライチェーン管理ソリューションへのニーズが高まっています。さらに、医薬品の偽造は世界的な問題であり、公衆衛生に大きな脅威を与えています。偽造医薬品は、誤った用量や有害物質を含んでいる可能性があり、治療や治癒の失敗、病気の長期化、死亡といった深刻な健康被害をもたらす。
医薬品セキュリティ研究所が発表した推計によると、偽造医薬品の取引事件は著しく増加しており、137カ国において2016年の3146件から2020年には4344件に38%増加しました。その上、2020年には、すべての治療カテゴリーから2451種類の医薬品が関与しています。したがって、製薬業界は、サプライチェーン全体を通じて医薬品の安全性と真正性を確保するための対策を実施することに多大な圧力を受けており、予測期間中の世界の医薬品サプライチェーン管理市場の成長を後押ししています。
地域別インサイト
世界の医薬品サプライチェーンマネジメント市場の成長分析には、アジア太平洋、北米、ヨーロッパ、その他の地域の研究が含まれています。アジア太平洋地域は、予測期間中、最も高いCAGRで上昇すると予測されています。この地域の市場成長は、インターネットやモバイルデバイスの普及、アジア太平洋地域の大規模な製薬産業、先端技術の採用の急増に起因しています。
競争に関する洞察
医薬品サプライチェーンマネジメントの世界市場における競争は、予測期間中に激しくなると予想されます。また、世界市場で事業を展開する主なプレーヤーは、McKesson Corporation、Tecsys Inc、Inforなどです。
当社のレポート提供内容は以下の通りです:
- 市場全体の主要な調査結果を探る
- 市場ダイナミクス(推進要因、抑制要因、機会、課題)の戦略的な内訳分析
- すべてのセグメント、サブセグメント、地域について、最低9年間の市場予測、および3年間の過去データ
- 市場セグメンテーション:主要なセグメントを徹底的に評価し、その市場規模を推定します。
- 地域別分析:地域および国別セグメントの評価とその市場占有率
- 主要な分析ポーターのファイブフォース分析、ベンダーランドスケープ、オポチュニティマトリックス、主要な購買基準など。
- 競合環境は、主要企業を要因や市場シェアなどに基づいて理論的に説明するものです。
- 企業プロファイリング:詳細な会社概要、提供する製品/サービス、SCOT分析、最近の戦略的展開など。


ページTOPに戻る


目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. INCREASING APPLICATION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
3.1.2. ADOPTION OF GS1 STANDARD SYSTEM
3.1.3. GROWING PRESSURE TO REDUCE HEALTHCARE COSTS
3.1.4. SURGING DEMAND FOR PHARMACEUTICALS PRODUCTS
3.1.5. HIGH PREVALENCE OF DRUG COUNTERFEITING
3.2. KEY RESTRAINTS
3.2.1. STRINGENT REGULATIONS IN HEALTHCARE DATA EXCHANGE
3.2.2. HIGH OPERATIONAL COSTS OF HEALTHCARE SCM SOFTWARE
3.2.3. TECHNICAL PROBLEMS ASSOCIATED WITH SCM SOFTWARE
3.2.4. SECURITY ISSUES IN WEAK SCM LINKS
4. KEY ANALYTICS
4.1. KEY TECHNOLOGY TRENDS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET CONCENTRATION ANALYSIS
4.5. MARKET MATURITY ANALYSIS
5. MARKET BY COMPONENT
5.1. SOLUTION
5.1.1. TRANSPORTATION MANAGEMENT SYSTEM
5.1.2. PLANNING & ANALYTICS
5.1.3. WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
5.1.4. PROCUREMENT & SOURCING
5.1.5. MANUFACTURING EXECUTION SYSTEM
5.2. SERVICE
5.2.1. PROFESSIONAL SERVICES
5.2.2. MANAGED SERVICES
6. MARKET BY DEPLOYMENT MODE
6.1. ON-PREMISE
6.2. CLOUD-BASED
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
7.1.3. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
7.1.4. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
7.1.5. KEY PLAYERS IN NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
7.1.6. COUNTRY ANALYSIS
7.1.6.1. UNITED STATES
7.1.6.1.1. UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.1.6.2. CANADA
7.1.6.2.1. CANADA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2. EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
7.2.3. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
7.2.4. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
7.2.5. KEY PLAYERS IN EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
7.2.6. COUNTRY ANALYSIS
7.2.6.1. UNITED KINGDOM
7.2.6.1.1. UNITED KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.2. GERMANY
7.2.6.2.1. GERMANY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.3. FRANCE
7.2.6.3.1. FRANCE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.4. ITALY
7.2.6.4.1. ITALY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.5. SPAIN
7.2.6.5.1. SPAIN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.6. NORDIC COUNTRIES
7.2.6.6.1. NORDIC COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.7. REST OF EUROPE
7.2.6.7.1. REST OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3. ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
7.3.3. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
7.3.4. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
7.3.5. KEY PLAYERS IN ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
7.3.6. COUNTRY ANALYSIS
7.3.6.1. CHINA
7.3.6.1.1. CHINA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.2. JAPAN
7.3.6.2.1. JAPAN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.3. INDIA
7.3.6.3.1. INDIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.4. SOUTH KOREA
7.3.6.4.1. SOUTH KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.5. AUSTRALIA & NEW ZEALAND
7.3.6.5.1. AUSTRALIA & NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.6. REST OF ASIA-PACIFIC
7.3.6.6.1. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.4. REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
7.4.3. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
7.4.4. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
7.4.5. KEY PLAYERS IN REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
7.4.6. REGIONAL ANALYSIS
7.4.6.1. LATIN AMERICA
7.4.6.1.1. LATIN AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.4.6.2. MIDDLE EAST & AFRICA
7.4.6.2.1. MIDDLE EAST & AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. PRODUCT LAUNCHES
8.1.2. PARTNERSHIPS
8.2. COMPANY PROFILES
8.2.1. ARVATO SUPPLY CHAIN SOLUTIONS
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCTS / SERVICES LIST
8.2.2. CARDINAL HEALTH
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCTS / SERVICES LIST
8.2.2.3. STRENGTHS & CHALLENGES
8.2.3. EPICOR SOFTWARE CORPORATION
8.2.3.1. COMPANY OVERVIEW
8.2.3.2. PRODUCTS / SERVICES LIST
8.2.4. GLOBAL HEALTHCARE EXCHANGE LLC
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCTS / SERVICES LIST
8.2.4.3. STRENGTHS & CHALLENGES
8.2.5. INFOR
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCTS / SERVICES LIST
8.2.5.3. STRENGTHS & CHALLENGES
8.2.6. JUMP TECHNOLOGIES
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCTS / SERVICES LIST
8.2.7. LOGITAG SYSTEMS
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCTS / SERVICES LIST
8.2.8. MANHATTAN ASSOCIATES
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCTS / SERVICES LIST
8.2.8.3. STRENGTHS & CHALLENGES
8.2.9. MCKESSON CORPORATION
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCTS / SERVICES LIST
8.2.9.3. STRENGTHS & CHALLENGES
8.2.10. ORACLE CORPORATION
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCTS / SERVICES LIST
8.2.10.3. STRENGTHS & CHALLENGES
8.2.11. SAP SE
8.2.11.1. COMPANY OVERVIEW
8.2.11.2. PRODUCTS / SERVICES LIST
8.2.11.3. STRENGTHS & CHALLENGES
8.2.12. SPECTRUM HEALTH
8.2.12.1. COMPANY OVERVIEW
8.2.12.2. PRODUCTS / SERVICES LIST
8.2.13. TECSYS INC
8.2.13.1. COMPANY OVERVIEW
8.2.13.2. PRODUCTS / SERVICES LIST
8.2.13.3. STRENGTHS & CHALLENGES
8.2.14. TERSO SOLUTION
8.2.14.1. COMPANY OVERVIEW
8.2.14.2. PRODUCTS / SERVICES LIST
8.2.14.3. STRENGTHS & CHALLENGES
8.2.15. VIZIENT INC
8.2.15.1. COMPANY OVERVIEW
8.2.15.2. PRODUCTS / SERVICES LIST

 

ページTOPに戻る


 

Summary

KEY FINDINGS
The global pharmaceutical supply chain management market is anticipated to grow with a CAGR of 8.84% during the forecast period, 2023 to 2032. Some of the top factors bolstering the market’s growth include the increasing application of cloud computing systems in healthcare, the adoption of the GS1 standard system, the mounting pressure to reduce healthcare costs, the surging demand for pharmaceutical products, and the high prevalence of drug counterfeiting.
MARKET INSIGHTS
Pharmaceutical supply chain management (SCM) software facilities the implementation, planning, as well as control of pharmaceutical product flow from the point of origin to consumption. The supply chain in the pharmaceutical industry includes the movement of active ingredients, finished products, raw materials, as well as medical devices from manufacturers to distributors, pharmacies, healthcare facilities, and wholesalers.
The surging incidence of drug counterfeiting in the pharmaceutical industry has generated an increasing need for effective supply chain management solutions. Furthermore, drug counterfeiting is a global problem that poses a substantial threat to public health. Counterfeit drugs may also comprise incorrect doses and harmful substances, resulting in serious health consequences like the failure of treatments or cures, increased risk of prolonged illness, and/or death.
As per the estimations issued by the Pharmaceutical Security Institute, incidents of counterfeit medicine trafficking have heightened significantly, with a 38% rise from 3146 in 2016 to 4344 in 2020 across 137 nations. Besides, in 2020, 2451 different drugs from all therapeutic categories were involved. Hence, the pharmaceutical industry is under tremendous pressure to implement measures that ensure drug safety and authenticity throughout the supply chain, thus propelling the global pharmaceutical supply chain management market growth during the forecasted period.
REGIONAL INSIGHTS
The global pharmaceutical supply chain management market growth analysis entails the study of the Asia-Pacific, North America, Europe, and Rest of World. Asia-Pacific is projected to rise with the highest CAGR during the forecast period. The region’s market growth is credited to the increased Internet and mobile device adoption, the sizable pharmaceutical industry in the Asia-Pacific, and the surging adoption of advanced technologies.
COMPETITIVE INSIGHTS
The competition in the global pharmaceutical supply chain management market is set to be high during the projection period. In addition, key players operating in the global market are McKesson Corporation, Tecsys Inc, Infor, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. INCREASING APPLICATION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
3.1.2. ADOPTION OF GS1 STANDARD SYSTEM
3.1.3. GROWING PRESSURE TO REDUCE HEALTHCARE COSTS
3.1.4. SURGING DEMAND FOR PHARMACEUTICALS PRODUCTS
3.1.5. HIGH PREVALENCE OF DRUG COUNTERFEITING
3.2. KEY RESTRAINTS
3.2.1. STRINGENT REGULATIONS IN HEALTHCARE DATA EXCHANGE
3.2.2. HIGH OPERATIONAL COSTS OF HEALTHCARE SCM SOFTWARE
3.2.3. TECHNICAL PROBLEMS ASSOCIATED WITH SCM SOFTWARE
3.2.4. SECURITY ISSUES IN WEAK SCM LINKS
4. KEY ANALYTICS
4.1. KEY TECHNOLOGY TRENDS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET CONCENTRATION ANALYSIS
4.5. MARKET MATURITY ANALYSIS
5. MARKET BY COMPONENT
5.1. SOLUTION
5.1.1. TRANSPORTATION MANAGEMENT SYSTEM
5.1.2. PLANNING & ANALYTICS
5.1.3. WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
5.1.4. PROCUREMENT & SOURCING
5.1.5. MANUFACTURING EXECUTION SYSTEM
5.2. SERVICE
5.2.1. PROFESSIONAL SERVICES
5.2.2. MANAGED SERVICES
6. MARKET BY DEPLOYMENT MODE
6.1. ON-PREMISE
6.2. CLOUD-BASED
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
7.1.3. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
7.1.4. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
7.1.5. KEY PLAYERS IN NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
7.1.6. COUNTRY ANALYSIS
7.1.6.1. UNITED STATES
7.1.6.1.1. UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.1.6.2. CANADA
7.1.6.2.1. CANADA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2. EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
7.2.3. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
7.2.4. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
7.2.5. KEY PLAYERS IN EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
7.2.6. COUNTRY ANALYSIS
7.2.6.1. UNITED KINGDOM
7.2.6.1.1. UNITED KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.2. GERMANY
7.2.6.2.1. GERMANY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.3. FRANCE
7.2.6.3.1. FRANCE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.4. ITALY
7.2.6.4.1. ITALY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.5. SPAIN
7.2.6.5.1. SPAIN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.6. NORDIC COUNTRIES
7.2.6.6.1. NORDIC COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.2.6.7. REST OF EUROPE
7.2.6.7.1. REST OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3. ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
7.3.3. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
7.3.4. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
7.3.5. KEY PLAYERS IN ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
7.3.6. COUNTRY ANALYSIS
7.3.6.1. CHINA
7.3.6.1.1. CHINA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.2. JAPAN
7.3.6.2.1. JAPAN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.3. INDIA
7.3.6.3.1. INDIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.4. SOUTH KOREA
7.3.6.4.1. SOUTH KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.5. AUSTRALIA & NEW ZEALAND
7.3.6.5.1. AUSTRALIA & NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.3.6.6. REST OF ASIA-PACIFIC
7.3.6.6.1. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.4. REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
7.4.3. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
7.4.4. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
7.4.5. KEY PLAYERS IN REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
7.4.6. REGIONAL ANALYSIS
7.4.6.1. LATIN AMERICA
7.4.6.1.1. LATIN AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
7.4.6.2. MIDDLE EAST & AFRICA
7.4.6.2.1. MIDDLE EAST & AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. PRODUCT LAUNCHES
8.1.2. PARTNERSHIPS
8.2. COMPANY PROFILES
8.2.1. ARVATO SUPPLY CHAIN SOLUTIONS
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCTS / SERVICES LIST
8.2.2. CARDINAL HEALTH
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCTS / SERVICES LIST
8.2.2.3. STRENGTHS & CHALLENGES
8.2.3. EPICOR SOFTWARE CORPORATION
8.2.3.1. COMPANY OVERVIEW
8.2.3.2. PRODUCTS / SERVICES LIST
8.2.4. GLOBAL HEALTHCARE EXCHANGE LLC
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCTS / SERVICES LIST
8.2.4.3. STRENGTHS & CHALLENGES
8.2.5. INFOR
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCTS / SERVICES LIST
8.2.5.3. STRENGTHS & CHALLENGES
8.2.6. JUMP TECHNOLOGIES
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCTS / SERVICES LIST
8.2.7. LOGITAG SYSTEMS
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCTS / SERVICES LIST
8.2.8. MANHATTAN ASSOCIATES
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCTS / SERVICES LIST
8.2.8.3. STRENGTHS & CHALLENGES
8.2.9. MCKESSON CORPORATION
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCTS / SERVICES LIST
8.2.9.3. STRENGTHS & CHALLENGES
8.2.10. ORACLE CORPORATION
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCTS / SERVICES LIST
8.2.10.3. STRENGTHS & CHALLENGES
8.2.11. SAP SE
8.2.11.1. COMPANY OVERVIEW
8.2.11.2. PRODUCTS / SERVICES LIST
8.2.11.3. STRENGTHS & CHALLENGES
8.2.12. SPECTRUM HEALTH
8.2.12.1. COMPANY OVERVIEW
8.2.12.2. PRODUCTS / SERVICES LIST
8.2.13. TECSYS INC
8.2.13.1. COMPANY OVERVIEW
8.2.13.2. PRODUCTS / SERVICES LIST
8.2.13.3. STRENGTHS & CHALLENGES
8.2.14. TERSO SOLUTION
8.2.14.1. COMPANY OVERVIEW
8.2.14.2. PRODUCTS / SERVICES LIST
8.2.14.3. STRENGTHS & CHALLENGES
8.2.15. VIZIENT INC
8.2.15.1. COMPANY OVERVIEW
8.2.15.2. PRODUCTS / SERVICES LIST

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Inkwood Research社はどのような調査会社ですか?


Inkwood Researchは世界40ヶ国以上の国を対象に広範な市場を調査し、世界市場全体を調査したレポートに加え、アジア太平洋地域、欧州、北米などの主要地域や主要国毎のレポートも数多く出版してい... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/16 10:26

159.45 円

174.07 円

209.46 円

ページTOPに戻る